Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2024

Summary of Significant Accounting Policies [Line Items]

Schedule of Exchange Rates

The following are the exchange rates that were used in translating the Company’s PRC subsidiaries’ financial statements into the consolidated financial statements:

	For the Years Ended December 31
	2024	2023	2022
Period Ended spot	US$1=RMB 7.2993	US$1=RMB 7.0999	US$1=RMB 6.8972
Period Average	US$1=RMB 7.1957	US$1=RMB 7.0809	US$1=RMB 6.7290

Schedule of Reconciliation of the Beginning and Ending Balances

The following is a reconciliation of the beginning and ending balances for convertible loans measured at fair value on a recurring basis using significant unobservable inputs (Level 3) as of December 31, 2024.

	December31, 2024
Opening balance	$	-
New convertible loans issued		4,985,000
Loss on change in fair value of convertible loan		678,297
Conversion of convertible loans		(5,663,297	)
Total	$	-

Schedule of Estimated Useful Lives

The Company calculates depreciation using the straight-line method, after consideration of the estimated residual values, over the following estimated useful lives:

Category	Useful lives	Estimated residual value
Buildings	20 years		10	%
Machinery and Equipment	10 years		10	%
Motor vehicles	5 years		10	%
Electronic Equipment	5 years		10	%
Office Equipment	3 years		10	%
Inspection Equipment	5 years		10	%

Schedule of Amortization of Finite-Lived Intangible Assets

Amortization of finite-lived intangible assets is computed using the straight-line method over the estimated useful lives, which is as follows:

Category	Useful lives
Land use rights	50 years
Patent	5 years
Trademark	10 years

Schedule of Disclosed Type of Revenue by Government Category

The Company has disclosed the type of revenue by government category as follows.

	December 31, 2024						December 31, 2023						December 31, 2022
	US$						US$						US$
Category	Produced		Purchased		Total		Produced		Purchased		Total		Produced		Purchased		Total
Class I		10,462,456		10,462,508		20,924,964		6,259,470		8,695,782		14,955,252		7,463,707		8,572,512		16,036,219
Class II		34,093,194		34,353,345		68,446,539		37,515,249		35,188,004		72,703,253		37,229,199		36,177,490		73,406,689
Class III		524,269		1,199,091		1,723,360		895,344		1,572,707		2,468,051		1,189,906		1,863,990		3,053,896
Others		2,526,422		3,288,357		5,814,779		3,526,606		3,445,753		6,972,359		4,632,164		6,217,373		10,849,537
Total		47,606,341		49,303,301		96,909,642		48,196,669		48,902,246		97,098,915		50,514,976		52,831,365		103,346,341

Schedule of Major Product Type Included in each Government Category

Furthermore, the Company has disclosed revenue by major product type included in each government category.

		December 31,		December 31,		December 31,
		2024		2023		2022
Category	Products	US$		US$		US$
Class I	Eye drops bottle		1,540,486		1,904,140		2,583,231
	Oral medicine bottle		2,804,649		2,900,606		3,965,345
	Anal bag		3,528,487		1,527,406		837,328
	Other Class I		13,051,342		8,623,100		8,650,315
Subtotal-Class I			20,924,964		14,955,252		16,036,219
Class II	Masks		150,666		55,428		410,163
	Identification tape		13,627,229		11,386,775		12,262,269
	Disposable medical brush		9,836,287		8,808,084		8,337,650
	Gynecological inspection kits		8,122,799		7,453,735		7,571,089
	Surgical kit		2,583,310		3,327,658		4,830,930
	Medical brush		5,110,705		5,776,772		5,231,299
	Medical kit		1,667,447		2,614,953		4,066,663
	Other Class II		27,348,096		33,279,848		30,696,626
Subtotal-Class II			68,446,539		72,703,253		73,406,689
Class III	Electronic pump		145,123		225,510		142,828
	Anesthesia puncture kit		335,460		326,671		539,615
	Disposable infusion pump		130,059		176,061		280,081
	Infusion pump		112,523		304,978		367,652
	Electronic infusion pump		3,987		967		44,812
	Laparoscopic trocar		31,206		44,783		139,284
	Other Class III		965,002		1,389,081		1,539,624
Subtotal-Class III			1,723,360		2,468,051		3,053,896
Others			5,814,779		6,972,359		10,849,537
Total			96,909,642		97,098,915		103,346,341

Goods [Member]

Summary of Significant Accounting Policies [Line Items]

Schedule of Type of Customers

The Company’s disaggregated revenues are represented by two categories which are type of goods and type of customers. 

	For the year ended December 31,
	2024		2023		2022
	US$		US$		US$
Self-Manufactured Products		47,606,340		48,196,669		50,514,976
Resales of Sourced Disposable Medical Devices from Third Party Manufacturers		49,303,302		48,902,246		52,831,365
Total Revenue		96,909,642		97,098,915		103,346,341

Customers [Member]

Summary of Significant Accounting Policies [Line Items]

Schedule of Type of Customers

Type of Customers

	For the year ended December 31,
	2024		2023		2022
	US$		US$		US$
Direct sales		6,766,636		8,077,373		9,465,644
Distributors		90,143,006		89,021,542		93,880,697
Total Revenue		96,909,642		97,098,915		103,346,341